Abstract Fertility preservation is a new subfield of reproductive medicine aimed at preserving the potential for genetic parenthood in adults or children at risk of sterility before undergoing anti-cancer treatments….
Abstract Since the first publications on the artificial ovary, many advances have been made. At that time, no studies had yet proved the feasibility of the concept, so it might…
Abstract Uterus transplantation (UTx) has now repeatedly shown that women with absolute uterine factor infertility (AUFI) can achieve both genetic and gestational motherhood [1–3]. Along with enabling the woman to…
Abstract According to the European Society of Human Reproduction and Embryology (ESHRE) Working Group on Oocyte Cryopreservation [], between 2010 and 2014, cancer patients in Europe underwent similar numbers of…
Abstract According to the most recent cancer statistics, more than 870,000 new diagnosis of cancer are expected in the US female population in 2018, with the three most common cancers…
Abstract With the advent of culture models for studying the process of ovarian folliculogenesis some 40 years ago, opportunities arose for the more systematic evaluation of the factors that regulated…
Abstract The field of female fertility preservation is based on the ability to successfully cryopreserve ovarian tissue [1], and this can now be offered to a wide range of patients…
Abstract Early detection and aggressive chemotherapy/radiotherapy treatments have improved the long-term survival rates for many young women with various types of cancer. As a consequence of these cytotoxic treatments, their…
Abstract Patients with cancer who desire to preserve their future reproductive potential but require immediate gonadotoxic treatments (chemo and/or radiotherapy) are left with few options for fertility preservation. These options…
Abstract Successful live births after transplantation of frozen-thawed human ovarian tissue have been observed since the first report in 2004 [1]. Up to 2017, approximately 130 live births have been…
